0% found this document useful (0 votes)
63 views2 pages

PROGRAMME BPaL

This document outlines a 4-day training program on updates to treatment guidelines for programmatic management of drug-resistant tuberculosis (PMDT). Day 1 covers screening and diagnosis of TB. Day 2 focuses on treatment of drug-susceptible and drug-resistant TB. Day 3 involves initiation of treatment, monitoring response, and management of active drug safety and special populations. Day 4 is for participant checkout after breakfast. Various doctors, nurses, and staff will present on topics like screening, diagnosis, treatment regimens, monitoring, and reporting.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
63 views2 pages

PROGRAMME BPaL

This document outlines a 4-day training program on updates to treatment guidelines for programmatic management of drug-resistant tuberculosis (PMDT). Day 1 covers screening and diagnosis of TB. Day 2 focuses on treatment of drug-susceptible and drug-resistant TB. Day 3 involves initiation of treatment, monitoring response, and management of active drug safety and special populations. Day 4 is for participant checkout after breakfast. Various doctors, nurses, and staff will present on topics like screening, diagnosis, treatment regimens, monitoring, and reporting.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

Republic of the Philippine

DEPARTMENT OF HEALTH
CENTER FOR HEALTH DEVELOPMENT-NORTHERN MINDANAO
J. V. Seriña Street, Carmen, Cagayan de Oro City
PABX (088) 8587123, (08822) 726476 / 727400 / 8587132 / 8582035/ 8584000 / 8585088
Email address: [email protected] Website: https://www.rho10.doh.gov.ph

PROGRAMME

Training on 2023 Key Updates to the Current Treatment Guidelines for the Programmatic
Management of Drug-Resistant Tuberculosis (PMDT)

Date & Time Topic/ Activity Person


Responsible

Day 1 (Feb 6, 2024)

12nn-1pm Arrival and Check-in of CHDNM Support Staff


Participants
Lunch
1pm-1:30pm Preliminaries Dr. Steffi Grace H. Enon,
Welcome Remarks MPM-HSD

1:30-2:30pm Screening for Tuberculosis Dr. Wellaflor Brito

2:30-3:30pm Diagnosis of Tuberculosis Dr. Ardel Padayhag

3:30-5pm NTP/NMTRL Policy Updates Ms. Renee Clutario

Day 2 (Feb 7, 2024)

8am-10:30am Treatment of Drug Dr. Ardel Padayhag


Susceptible TB
10:30am-12nn Key Updates to the Current Dr. Wellaflor Brito
Treatment Guidelines for the
Programmatic Management of
Drug-Resistant Tuberculosis
(PMDT)

Background and Key Updates

12nn-1pm Lunch Break

1pm-4:30pm Assigning the appropriate Dr. Leslie Magsayo Salon


treatment regimen:
 BPaLM/BPAL
 SSOR Lzd/Pto
Variation
 ITR

4:30pm-5pm Plenary

DOH-CHD10-MSDHRDU-SOP-03-FORM 3 REV.5
Republic of the Philippine
DEPARTMENT OF HEALTH
CENTER FOR HEALTH DEVELOPMENT-NORTHERN MINDANAO
J. V. Seriña Street, Carmen, Cagayan de Oro City
PABX (088) 8587123, (08822) 726476 / 727400 / 8587132 / 8582035/ 8584000 / 8585088
Email address: [email protected] Website: https://www.rho10.doh.gov.ph

Day 3 (Feb 8, 2024)

8am-11am Initiation of Treatment


Dr. Leslie Magsayo Salon
Updated weight-based dosing
(WHO)

11am-12nn Monitoring Response to


Treatment Dr. Claire Paglinawan

Treatment Outcome

Post Treatment Follow-Up

12nn-1pm Lunch Break

1pm-2:30pm Active Drug Safety Monitoring Dr. Leslie Magsayo Salon


and Management (aDSM)

2:30pm-3:00pm Rifampicin-resistant/ Dr. Claire Paglinawan


Multidrug-resistant
Tuberculosis (RR/MDR-TB) In
RR/MDR-TB In Individuals
Below 14 Years Old

3pm-3:30pm Rifampicin-susceptible and Dr. Claire Paglinawan


Isoniazid resistant TB (Hr-TB)

3:30pm-4:30pm Recording and Reporting Ms. Patrice Maan Baang

Ms. Sandra Ramayan

4:30pm-5pm Closing

Day 4 (Feb 9, 2024)

8am-9am Breakfast CHDNM Support Staff


Check out of Participants

DOH-CHD10-MSDHRDU-SOP-03-FORM 3 REV.5

You might also like